Cost-effectiveness of hepatitis A vaccine in prevention of secondary hepatitis A infection

被引:13
|
作者
Péchevis, M
Khoshnood, B
Buteau, L
Durand, I
Piquard, Y
Lafuma, A
机构
[1] EVAL, CEMKA, F-92340 Bourg La Reine, France
[2] GlaxoSmithKline, F-78163 Marly Le Roi, France
关键词
hepatitis A vaccine; secondary prevention; cost-effectiveness analysis;
D O I
10.1016/S0264-410X(03)00424-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Using a decision-tree based model, we investigated the cost-effectiveness of several vaccination strategies for household, day care center and nursery/primary school contacts of primary cases of hepatitis A in France. Depending on the age groups vaccinated, the cost per symptomatic case avoided varied between Euro 700 and 1300 ( Euro 1 = US$ 0.93) for household contacts. Vaccination of contacts in day care centers and schools resulted in cost-savings. However, these findings are contingent on the limited and controversial data available on vaccine protective efficacy. In particular, the question of the relative efficacy of vaccination as compared with the use of immunoglobulins needs further study. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3556 / 3564
页数:9
相关论文
共 50 条
  • [1] THE COST-EFFECTIVENESS OF HEPATITIS-B VACCINE
    DIENSTAG, JL
    SILVERSTEIN, MD
    MULLEY, AG
    [J]. JOURNAL OF INFECTION, 1983, 7 : 81 - 84
  • [2] COST-EFFECTIVENESS OF HEPATITIS-B VACCINE
    SELIGMAN, SJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (02): : 104 - 105
  • [3] The cost of hepatitis C and the cost-effectiveness of its prevention
    Shiell, A
    Law, MG
    [J]. HEALTH POLICY, 2001, 58 (02) : 121 - 131
  • [4] COST-EFFECTIVENESS OF HEPATITIS-A PREVENTION IN FRANCE
    SEVERO, CA
    FAGNANI, F
    LAFUMA, A
    [J]. PHARMACOECONOMICS, 1995, 8 (01) : 46 - 61
  • [5] Efficacy of hepatitis A vaccine in prevention of secondary hepatitis A infection: a randomised trial
    Sagliocca, L
    Amoroso, P
    Stroffolini, T
    Adamo, B
    Tosti, ME
    Lettieri, G
    Esposito, C
    Buonocore, S
    Pierri, P
    Mele, A
    [J]. LANCET, 1999, 353 (9159): : 1136 - 1139
  • [6] COST-EFFECTIVENESS OF HEPATITIS-B VACCINE IN THE GAMBIA
    HALL, AJ
    ROBERTSON, RL
    CRIVELLI, PE
    LOWE, Y
    INSKIP, H
    SNOW, SK
    WHITTLE, H
    [J]. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1993, 87 (03) : 333 - 336
  • [7] COST-EFFECTIVENESS OF HEPATITIS-B VACCINE - REPLY
    MULLEY, AG
    SILVERSTEIN, MD
    DIENSTAG, JL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (02): : 105 - 105
  • [8] Hepatitis A vaccine for secondary hepatitis A infection
    Monto, AS
    Victor, JC
    [J]. LANCET, 1999, 354 (9175): : 341 - 342
  • [9] COST-EFFECTIVENESS ANALYSIS OF HEPATITIS-A PREVENTION IN TRAVELERS
    TORMANS, G
    VANDAMME, P
    VANDOORSLAER, E
    [J]. VACCINE, 1992, 10 : S88 - S92
  • [10] Cost-effectiveness of treatment for chronic hepatitis C infection
    Bernstein, D
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (15): : 1993 - 1993